You're viewing a public preview of ImmunoGen, Inc. Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

ImmunoGen, Inc.

Inactive
Waltham,  Massachusetts (MA),  United States
Sector: Life Science Entity: Private Founded: 1981
Acquired ImmunoGen, Inc. acquired by AbbVie, Inc. in 2023
1981
Founded
Year established
2
Transactions
Sign up to view
$10.10B
Deal Value
Sign up to view
About ImmunoGen, Inc.
ImmunoGen, Inc. was a United States–based biopharmaceutical company focused on the development and commercialization of antibody-drug conjugates (ADCs) for the treatment of cancer. The company specialized in proprietary ADC technologies that combine monoclonal antibodies with cytotoxic agents to selectively target and destroy cancer cells. Its portfolio included oncology therapies and clinical-stage product candidates for solid tumors and hematologic malignancies, as well as technology licensing collaborations with global pharmaceutical companies. ImmunoGen conducted research, clinical development, regulatory, and commercialization activities supporting innovative cancer treatments. The company was founded in 1981 and was headquartered in Waltham, Massachusetts, United States.
Investors
Current Investors
AbbVie, Inc. ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
2 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 2 Transactions
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
ImmunoGen, Inc. M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does ImmunoGen, Inc. do?
ImmunoGen, Inc. was a United States–based biopharmaceutical company focused on the development and commercialization of antibody-drug conjugates (ADCs) for the treatment of cancer. The company specialized in proprietary ADC technologies that combine monoclonal antibodies with cytotoxic agents to s
Where is ImmunoGen, Inc. headquartered?
ImmunoGen, Inc. is headquartered in Waltham, Massachusetts (MA), United States.
When was ImmunoGen, Inc. founded?
ImmunoGen, Inc. was founded in 1981.
What sector is ImmunoGen, Inc. in?
ImmunoGen, Inc. operates in the Life Science sector.
Who are the investors in ImmunoGen, Inc.?
Current investors in ImmunoGen, Inc. include AbbVie, Inc.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has ImmunoGen, Inc. been involved in?
ImmunoGen, Inc. has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full ImmunoGen, Inc. profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access ImmunoGen, Inc.'s complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial